Why Goodrich Petroleum, WebMD, and Edwards Lifesciences Are Today's 3 Best Stocks

We knew it'd take strong economic data to break the broad-based S&P 500 out of its recent funk, and we finally got it this morning.

Surprisingly strong U.S. retail sales data this morning lit a spark under the market which helped end the S&P 500's two-day losing streak. According to the Commerce Department, U.S. retail sales galloped higher by a whopping 1.1% in March as consumers came out of their homes to shop with a vengeance after a very cold winter. Although retailers, big and small, are likely set up for a rough quarter because of the polar vortex, this March surge sets the stage for a rebound in the second quarter.

The start to earnings season also has investors excited with a number of the nation's largest banks kicking things off. As with most earnings seasons there's little reason for investors to worry about corporate growth until there's actually a reason to (i.e., don't worry about a fire until you see smoke). It may be early, but we haven't been given any reasons for investors to duck and cover as of yet, so that also likely helped contribute to today's upside move.

By day's end, the S&P 500 had advanced by 14.92 points (0.82%) to close at 1,830.61.

Source: Eric Kounce, Wikimedia Commons.

The big gainer of the day, by a long shot, was oil and gas exploration and development company Goodrich Petroleum , which jumped 30.2% after announcing the completion of the Blades 33H-1 well in Tangipahoa Parish, La. As the company noted in its press release, the well achieved a peak 24-hour average production rate of 1,270 barrels of oil equivalent. Furthermore, Goodrich notes that the well was completed under budget. At the moment, Goodrich has three wells up and running on its 300,000 net acres and plans to bring that total to five by the end of the year if recovery success continues. Considering that 59.5% of Goodrich's shares are currently held short, it's little wonder why shares rocketed to the upside. With substantial debt and ongoing losses I'd remain cautious about Goodrich's outlook here, but with short-sellers in a bind to cover, there may be some very short-term additional upside in the stock.

Online and mobile health information services provider WebMD surged 16.5% after it announced that its first-quarter revenue and EBITDA should be at the high-end of previous forecasts. WebMD's CEO David Schlanger attributed the strength to higher second-half sales activity in Q1, with the company generating a whopping 3.5 billion page views during the quarter. For the full-year, WebMD's forecast of $545 million to $575 million in revenue remains in-line with Wall Street's expectations. While I'm certainly pleased to see WebMD's top-line growth moving higher, I'd personally attribute this strength to the uncertainties surrounding Obamacare than anything else. WebMD has shown a penchant for erratic earnings growth of late and that's more than enough to keep me parked on the sidelines.

Medtronic Mounds View Campus, Source: Medtronic.

Finally, surgical heart valve products developer Edwards Lifesciences climbed 11% after a Delaware court levied an injunction on sales of Medtronic's CoreValve system which is set to begin this coming Friday. The ruling stems from a patent litigation case brought against Medtronic by Edwards Lifesciences whereby Medtronic's CoreValve was found to have infringed on Edward's Andresen transcatheter aortic value replacement patent. The two parties will now need to confer and decide in what instances CoreValve can still be used, although Medtronic has made no qualms about its intention to appeal the decision. This is certainly a win for Edwards Lifesciences, but shareholders will want to keep in mind that this decision only pertains to sales of CoreValve within the U.S., not around the world, and that Edwards' current valuation looks a bit frothy next to its 5% top-line growth expectations.

These three stocks may have soared today, but they'll likely be hard-pressed to keep pace with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

The article Why Goodrich Petroleum, WebMD, and Edwards Lifesciences Are Today's 3 Best Stocks originally appeared on Fool.com.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story